As a board certified family practice doctor specializing in integrative medicine and weight management, my relationship with Semaglutide, known commercially as Wegovy and Ozempic, is a complex blend of admiration and caution. Semaglutide, part of the GLP-1 receptor agonist class, has been revolutionary in treating obesity and type 2 diabetes. By mimicking the GLP-1 hormone, it enhances insulin secretion, inhibits glucagon, and effectively suppresses appetite. These mechanisms make it a powerful tool in achieving weight loss and improving glycemic control.
However, it is important to acknowledge the potential side effects and concerns associated with Semaglutide. Common side effects include nausea, vomiting, diarrhea, and constipation. More serious concerns involve the risk of thyroid C-cell tumors, including medullary thyroid carcinoma. While these risks were primarily observed in rodent studies, they have raised concerns about long-term safety in humans. Consequently, patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2) are generally advised against using this medication.
Recent media reports suggest that patients might need to remain on this medication indefinitely to sustain weight loss. I challenge this narrative, particularly for the majority of non-diabetic patients. The issue lies not in a genetic defect for most, but in long-standing lifestyle and dietary habits. Consider an analogy: if muscle pain due to a body imbalance is only treated with advil without addressing the underlying cause, the pain will resurface once the medication is stopped. Similarly, GLP-1s can assist in weight loss, but without addressing the root causes—such as poor nutrition and sedentary lifestyle—the benefits will likely not last.
To elaborate, GLP-1 receptor agonists like Semaglutide work by mimicking the action of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). This hormone is released in the gut in response to food intake and plays a crucial role in regulating blood sugar levels by enhancing insulin secretion and inhibiting glucagon release. Additionally, it slows gastric emptying and promotes satiety, making individuals feel full longer and reducing overall food intake. These effects collectively contribute to significant weight loss and improved metabolic health.
Despite these benefits, the underlying issue for most individuals is not a genetic anomaly but rather acquired habits and lifestyle choices. Many people fall into a vicious cycle of “metabolic syndrome”, where excess adipose tissue perpetuates hormonal imbalances, further promoting fat storage. Over time, poor dietary choices and lack of physical activity become ingrained habits, leading to weight gain and associated health problems. While GLP-1 agonists can act as a temporary metabolic reset, sustainable change requires a fundamental shift in lifestyle and behavior.
This is where our approach at Love Health comes into play. In addition to our primary care services, we’ve developed a comprehensive Healthy Lifestyle Coaching program in partnership with a certified integrative nutrition coach and hypnotherapist/life coach. Our program offers a multidisciplinary team approach, including continuous glucose monitoring, accountability calls, weekly and monthly check-ins, community support, access to necessary labs and medications, and much more. Our aim is to empower patients to adopt healthier habits and ultimately discontinue the need for medications like Semaglutide.
Rewiring the brain to establish new, healthier habits is crucial. Neuroplasticity, the brain’s ability to reorganize itself by forming new neural connections, allows us to learn new behaviors and unlearn detrimental ones. Just as we learn new directions or routes to reach a destination, we can rewire our brains to make better lifestyle choices. With appropriate guidance and support, individuals can break the cycle of metabolic syndrome and achieve lasting health improvements.
At Love Health, our ultimate goal is for patients to no longer need our program or medication. However, we welcome those who choose to continue with us for primary care. We prioritize human autonomy and do not require you to sign any financial contracts. Our philosophy is that with proper support and education, most individuals can achieve sustainable weight loss and improved health, proving that lifelong dependence on medications like Semaglutide is not a necessity.
In conclusion, while Semaglutide and other GLP-1 receptor agonists are valuable tools in the fight against obesity and metabolic disorders, they are not a cure-all. Addressing the root causes of unhealthy weight gain through lifestyle changes is essential for long-term success. At Love Health, we are committed to helping patients achieve this balance, offering a holistic approach that promotes lasting health and wellness.
For all the latest news, follow us on Facebook or sign up for Glenside Local’s “Daily Buzz” newsletter here.